As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Learn more: PMC Disclaimer | PMC Copyright Notice
J Clin Invest. 1995 Mar; 95(3): 923.
doi: 10.1172/JCI117798
PMCID: PMC441421
PMID: 7883990
The potential significance of beta 3 adrenergic receptors.
See the article "A pathogenic role of visceral fat beta 3-adrenoceptors in obesity." on page 1109.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (217K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arch JR, Kaumann AJ. Beta 3 and atypical beta-adrenoceptors. Med Res Rev. 1993 Nov;13(6):663–729. [PubMed] [Google Scholar]
- Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD. Molecular characterization of the human beta 3-adrenergic receptor. Science. 1989 Sep 8;245(4922):1118–1121. [PubMed] [Google Scholar]
- Emorine L, Blin N, Strosberg AD. The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci. 1994 Jan;15(1):3–7. [PubMed] [Google Scholar]
- Lönnqvist F, Thöme A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest. 1995 Mar;95(3):1109–1116. [PMC free article] [PubMed] [Google Scholar]
- Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 1993 Dec 23;366(6457):740–742. [PubMed] [Google Scholar]
Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation